calfhood
diseas
play
key
role
economi
dairi
farm
increas
oper
cost
reduc
longterm
product
anim
incid
diseas
associ
increas
mortal
rate
enter
common
diagnosi
young
calv
accord
svensson
linder
olsson
contribut
calf
loss
first
day
life
neonat
calv
prone
sick
immun
system
immatur
furthermor
process
birth
caus
elev
stress
level
newborn
exposur
oxygenrich
environ
lead
increas
gener
reactiv
oxygen
speci
reactiv
oxygen
speci
induc
peroxid
lipid
macromolecul
lead
alter
cellular
compon
interact
signal
cascad
modif
physiolog
cell
function
properli
counterbalanc
antioxid
defens
excess
product
reactiv
oxygen
speci
result
oxid
stress
cofactor
diseas
human
farm
anim
adequ
colostrum
suppli
vital
calv
colostrum
ensur
ingest
nutrient
contain
immunoglobulin
ig
peptid
antioxid
bioactiv
factor
support
matur
antioxid
immun
defens
well
local
intestin
immun
ban
antibiot
perform
promot
european
union
increas
effort
establish
natur
altern
enhanc
health
product
breed
special
focu
direct
phytochem
use
manifold
accord
respect
compound
flavonoid
secondari
plant
metabolit
wide
distribut
plant
kingdom
abl
modul
inflamm
immun
function
exert
antioxid
activ
quercetin
belong
subclass
flavonol
ubiquit
plant
interest
scientist
benefici
use
human
farm
anim
antioxid
capac
amelior
acquisit
passiv
immun
neonat
base
find
feed
antioxidantenrich
colostrum
enhanc
igg
absorpt
antioxid
statu
newborn
calv
piglet
similarli
retskii
et
al
show
correct
antioxid
balanc
newborn
calv
prior
first
colostrum
ingest
increas
acquisit
colostr
immun
reduc
incid
enter
colibacillosi
anoth
benefici
effect
quercetin
local
action
gastrointestin
tract
vitro
studi
intestin
epithelium
demonstr
quercetin
downregul
express
gene
relat
inflamm
inflam
epithelium
lozoya
et
al
show
clinic
studi
oral
quercetin
administr
reduc
abdomin
pain
acut
diarrheic
diseas
human
guinea
pig
mice
rat
inhibitori
action
quercetin
prostaglandin
ileal
contract
castoroilinduc
diarrhea
demonstr
furthermor
quercetin
act
prebiot
thu
inhibit
adhes
enteropathogen
cell
without
affect
viabil
probiot
improv
perform
hen
modul
cecal
microflora
popul
although
multitud
research
quercetin
perform
vitro
anim
model
medic
condit
studi
effect
neonat
farm
anim
scarc
aim
present
work
investig
potenti
healthpromot
effect
feed
quercetin
newborn
calv
first
week
life
evalu
whether
healthpromot
effect
quercetin
compens
initi
colostrum
depriv
calv
hypothes
quercetin
improv
antioxid
balanc
immun
function
local
antibacteri
antiinflammatori
effect
reduc
incid
diarrhea
gastrointestin
dysfunct
navel
disinfect
povidon
iodin
solut
vetsept
animedica
germani
neonat
calv
receiv
oral
dose
g
iron
dextran
first
meal
day
ursoferran
serumwerk
bernburg
bernburg
germani
support
immunolog
defens
first
day
life
calv
receiv
chicken
eggderiv
immunoglobulin
morn
feed
gkg
bodi
weight
globigen
life
start
ew
nutrit
visbek
germani
prevent
cryptosporidiosi
calv
treat
halofuginon
mgkg
bodi
weight
per
os
halocur
intervet
igovil
franc
even
feed
day
day
colostrumdepriv
calv
forq
forq
addit
receiv
bvitamin
mg
nicotinamidecalf
mg
thiamin
chlorid
hydrochloridecalf
sc
vitaminbkomplex
serumwerk
bernburg
germani
bovin
colostr
immunoglobulin
day
sc
per
os
g
gammaglobulinscalf
antibodi
escherichia
coli
rotaviru
coronaviru
aniserin
orinject
animedica
germani
furthermor
formulaf
calv
treat
metaphylact
colistin
sulfat
day
day
mgkg
bodi
weight
im
belacol
belapharm
vechta
germani
calv
weigh
immedi
birth
even
meal
day
everi
morn
health
statu
examin
appetit
gener
condit
heart
rate
respiratori
rate
rectal
temperatur
gut
motil
assess
fecal
fluiditi
score
accord
larson
et
al
calv
reduc
vital
first
day
life
allow
one
recoveri
day
sampl
take
case
time
refer
day
result
section
day
birth
respect
due
gastrointestin
imbal
two
calv
one
calf
group
colq
one
calf
group
forq
exclud
studi
basal
blood
sampl
taken
morn
feed
day
jugular
vein
use
evacu
tube
contain
either
potassiumedta
mgml
edta
analys
plasma
metabolit
insulin
glucagon
immunoglobulin
acutephas
protein
liheparin
iu
heparin
determin
cortisol
flavonol
concentr
antioxid
statu
plasma
flavonol
analysi
addit
blood
sampl
taken
morn
feed
day
centrifug
g
min
plasma
aliquot
store
analys
analys
flavonol
concentr
antioxid
statu
respect
plasma
concentr
flavonol
quercetin
isorhamnetin
tamarixetin
kaempferol
measur
via
hplc
previous
describ
detect
limit
nmoll
recoveri
rate
intra
interassay
coeffici
respect
plasma
metabolit
analyz
use
automat
spectrophotomet
abx
pentra
horiba
abx
montpelli
franc
respect
kit
glucos
lactat
albumin
triacylglycerid
horiba
abx
montpelli
franc
total
protein
cholesterol
mtidiagnost
idstein
germani
urea
ltur
labortechnik
e
lehmann
berlin
germani
nonesterifi
fatti
acid
wako
chemic
neuss
germani
plasma
concentr
insulin
glucagon
determin
ria
use
kit
drg
instrument
marburg
germani
adapt
bovin
intra
interassay
coeffici
variat
insulin
glucagon
respect
plasma
cortisol
concentr
analyz
duplic
extract
diethyleth
use
commerci
avail
elisa
kit
drg
instrument
gmbh
marburg
germani
accord
instruct
manufactur
cross
reactiv
antibodi
corticosteron
progesteron
respect
compet
plasma
steroid
assay
valid
use
bovin
plasma
test
sensit
intra
interassay
coeffici
variat
concentr
igm
well
acutephas
protein
haptoglobin
serum
amyloid
fibrinogen
measur
edta
plasma
sampl
taken
day
analyz
radial
immunodiffus
modifi
gasowska
stefaniak
use
bovin
refer
serum
bethyl
laboratori
inc
montgomeri
usa
standard
igm
determin
elisa
use
kit
bethyl
laboratori
inc
montgomeri
usa
intraassay
coeffici
variat
igm
respect
detect
limit
igm
detect
serum
amyloid
saa
use
multispeci
elisa
kit
tridelta
develop
maynooth
ireland
detect
limit
saa
mgl
intraassay
coeffici
variat
haptoglobin
concentr
analyz
use
guaiacol
method
develop
jone
mould
human
haptoglobin
hp
sigma
standard
detect
limit
haptoglobin
gl
plasma
fibrinogen
determin
rapid
heat
precipit
accord
millar
simpson
stalker
liheparin
plasma
sampl
taken
day
use
analyz
troloxequival
antioxid
capac
teac
trolox
equival
te
mmoll
ferric
reduc
abil
plasma
frap
ascorb
acid
equival
asc
paramet
antioxid
capac
well
thiobarbitur
acid
reactiv
speci
tbar
malondialdehyd
equival
mdae
ngl
marker
oxid
stress
teac
analyz
describ
miller
et
al
modifi
et
al
frap
tbar
determin
accord
luehr
et
al
determin
commerci
elisa
kit
enzo
life
scienc
laus
switzerland
use
crossreact
assay
respect
eicosanoid
day
liver
biopsi
conduct
h
morn
meal
use
custommad
biopsi
trocar
biopsi
tissu
immedi
frozen
liquid
nitrogen
store
analysi
hippocalcinlik
lowdens
lipoprotein
rna
polymeras
ii
use
refer
gene
given
access
number
relat
nih
genbank
primer
sequenc
access
number
pcr
condit
target
gene
relat
antioxid
statu
catalas
cat
glutathion
peroxidas
superoxid
dismutas
sod
inflamm
tumor
necrosi
factor
tnf
haptoglobin
hp
fibrinogen
fga
serum
amyloid
creactiv
protein
crp
list
tabl
recent
describ
primer
product
verifi
sequenc
use
bigdy
termin
cycl
sequenc
kit
abi
genet
analyz
life
technolog
carlsbad
usa
realtim
pcr
perform
use
lightcycl
roch
molecular
biochem
mannheim
germani
sybr
green
use
fluoresc
dye
melt
curv
analysi
agaros
gel
electrophoresi
use
confirm
specif
pcr
product
quantif
cycl
valu
amplif
effici
obtain
use
linregpcr
version
import
qbase
version
biogazel
gent
belgium
subsequ
calcul
qualiti
control
geometr
mean
refer
gene
abund
use
normal
data
present
ratio
copi
number
gene
interest
geometr
mean
refer
gene
abund
statist
analys
conduct
use
sa
softwar
version
window
sa
institut
inc
cari
usa
descript
statist
test
normal
calcul
use
univari
procedur
base
sa
softwar
bodi
weight
averag
daili
weight
gain
data
hepat
gene
express
analyz
anova
mix
procedur
sasstat
take
model
fix
factor
diet
level
col
vs
quercetin
level
q
vs
q
interact
feed
intak
bodi
temperatur
heart
respiratori
rate
plasma
concentr
metabolit
hormon
flavonol
marker
antioxid
statu
analyz
repeat
measur
anova
use
mix
procedur
sasstat
softwar
model
fix
factor
diet
quercetin
day
life
repeat
variabl
interact
fix
factor
repeat
measur
calf
taken
account
use
repeat
statement
mix
procedur
type
block
diagon
residu
covari
matrix
chosen
depend
level
day
life
concentr
plasma
metabolit
hormon
data
antioxid
statu
plasma
unstructur
type
use
plasma
concentr
flavonol
acutephas
protein
ig
compound
symmetri
type
use
data
heart
respiratori
rate
well
bodi
temperatur
feed
intak
autoregress
type
appli
leastsquar
mean
lsm
standard
error
se
comput
fix
effect
model
pairwis
differ
lsm
test
tukeykram
procedur
slice
statement
mix
procedur
use
conduct
partit
analys
lsm
interact
fecal
score
analyz
gener
linear
mix
model
use
glimmix
procedur
sasstat
poisson
model
fix
factor
diet
quercetin
day
life
repeat
variabl
interact
fix
factor
repeat
measur
anim
taken
account
residu
option
random
statement
glimmix
procedur
use
compound
symmetri
structur
block
diagon
residu
covari
matrix
sick
frequenc
calv
respect
diet
quercetin
analyz
freq
procedur
sasstat
softwar
use
twoway
tabl
diet
sick
quercetin
sick
exact
pearson
chisquar
test
effect
differ
consid
signific
p
mean
bodi
weight
birth
kg
increas
age
p
gd
without
group
differ
respect
calv
receiv
first
meal
h
birth
milk
intak
relat
bodi
weight
differ
among
group
day
lower
day
colostrumdepriv
calv
p
fig
day
appetit
reduc
formulaf
calv
amount
tubef
milk
higher
colostrumf
calv
p
fig
heart
rate
decreas
age
p
respiratori
rate
tend
decreas
p
fig
rectal
temperatur
highest
day
subsequ
decreas
p
rectal
temperatur
fecal
score
higher
formulaf
colostrumf
calv
p
fig
number
calv
allow
recoveri
day
similar
among
group
except
colq
treat
one
calf
per
group
medic
navel
infect
four
calv
group
forq
need
antispasmodicanalges
treatment
recoveri
day
abdomin
pain
thu
colf
calv
tend
less
suscept
ill
p
wherea
quercetin
treatment
affect
wellb
p
due
sever
diseas
remov
two
calv
studi
day
forq
day
colq
preprandi
concentr
total
flavonol
plasma
day
first
quercetin
supplement
reveal
signific
differ
among
group
low
concentr
detect
five
colostrumf
calv
control
group
forq
colq
plasma
concentr
chang
age
colq
forq
plasma
flavonol
concentr
chang
age
p
reach
maximum
day
decreas
subsequ
tend
differ
among
group
day
p
fig
compar
flavonol
fraction
plasma
quercetin
fraction
total
flavonoid
highest
dietari
group
concentr
isorhamnetin
tamarixetin
day
higher
colq
forq
fig
plasma
glucos
concentr
lowest
day
increas
day
colq
forq
forq
p
decreas
day
forq
forq
p
mean
plasma
concentr
glucos
higher
colostrumf
formulaf
calv
p
tabl
plasma
lactat
nonesterifi
fatti
acid
concentr
highest
day
decreas
age
p
without
group
differ
tabl
concentr
total
protein
plasma
increas
colostrumf
calv
p
higher
colostrumf
formulaf
calv
day
day
day
p
fig
plasma
albumin
decreas
age
p
group
fig
total
protein
albumin
interact
signific
p
plasma
urea
concentr
increas
day
formulaf
day
colostrumf
calv
p
tabl
plasma
triglycerid
concentr
increas
day
colostrumf
calv
p
continu
decreas
day
day
formulaf
calv
p
plasma
cholesterol
concentr
increas
age
p
plasma
triglycerid
day
cholesterol
concentr
day
day
higher
colostrumf
formulaf
calv
p
tabl
plasma
insulin
concentr
decreas
age
p
tabl
glucagon
increas
maximum
plasma
concentr
day
subsequ
decreas
calv
p
glucagon
concentr
day
day
higher
colostrumf
formulaf
calv
p
tabl
cortisol
concentr
decreas
age
group
p
decreas
earlier
colostrumf
calv
mean
cortisol
concentr
plasma
first
week
life
lower
colostrumf
formulaf
calv
p
tabl
quercetin
treatment
affect
concentr
metabolit
hormon
plasma
plasma
concentr
increas
day
colostrumf
calv
p
fig
plasma
concentr
igm
increas
sharpli
day
colostrumf
calv
slowli
decreas
p
formulaf
group
igm
concentr
increas
day
p
still
lower
colostrumf
group
p
end
trial
fig
concentr
haptoglobin
blood
plasma
detect
limit
day
calv
increas
formulaf
calv
p
highest
forq
day
fig
mean
haptoglobin
concentr
higher
formulaf
colostrumf
calv
p
concentr
serum
amyloid
increas
day
slowli
decreas
afterward
calv
p
fig
concentr
fibrinogen
increas
day
decreas
p
without
differ
among
group
fig
howev
mean
fibrinogen
concentr
tend
higher
formula
feed
p
plasma
teac
increas
group
day
life
p
higher
colostrumf
formulaf
calv
p
fig
frap
decreas
day
day
formulaf
group
p
higher
p
day
colostrumf
group
fig
although
statist
signific
frap
decreas
delay
quercetinf
calv
compar
control
group
mean
concentr
tbar
plasma
higher
colostrumf
formulaf
calv
p
reveal
interact
p
higher
concentr
colostrumf
formulaf
calv
day
fig
mean
concentr
decreas
day
day
p
calv
tend
increas
day
forq
p
fig
regard
inflamm
marker
rel
mrna
abund
tnf
higher
quercetin
feed
p
tabl
rel
mrna
abund
crp
higher
p
tend
higher
p
formulaf
colostrumf
group
tabl
antioxid
enzym
mrna
abund
cat
tend
higher
colq
colq
p
differ
forq
forq
reveal
interact
p
tabl
studi
abl
confirm
oral
bioavail
quercetin
colostrumf
calv
show
colostrum
depriv
quercetin
absorb
equal
amount
indic
earlier
oral
bioavail
decreas
age
due
intestin
matur
therefor
reduc
permeabl
effect
elimin
process
pattern
flavonol
fraction
plasma
studi
differ
pattern
calv
adult
cattl
compar
observ
calv
result
explain
matur
intestin
metabol
shown
rat
pig
oral
administ
flavonol
undergo
complet
metabol
insid
intestin
mucosa
glucuronid
major
import
although
flavonol
present
plasma
quercetinf
calv
fail
detect
effect
metabol
paramet
hormon
concentr
also
case
previou
studi
cattl
howev
could
confirm
varieti
effect
caus
colostrumdepriv
first
day
life
cortisol
crucial
initi
parturit
catabol
activ
especi
hypoxia
birth
howev
decreas
plasma
cortisol
concentr
delay
formulaf
calv
seen
previou
studi
assum
delay
possibl
caus
either
abdomin
pain
reduc
util
nutrient
proven
increas
stress
paramet
sheep
higher
plasma
glucos
colostrumf
group
like
caus
enhanc
intestin
matur
therefor
enlarg
absorpt
surfac
addit
colostrum
feed
seem
acceler
matur
pancrea
glucagon
concentr
also
higher
colostrumf
calv
day
onward
although
basal
insulin
concentr
similar
among
dietari
group
show
companion
paper
postprandi
insulin
respons
pronounc
colostrumf
group
higher
triglycerid
cholesterol
concentr
colostrumf
calv
accord
observ
studi
due
enhanc
stimul
intestin
differenti
colostr
growth
factor
hormon
howev
must
consid
diarrhea
formulaf
calv
acceler
intestin
transit
therefor
reduc
absorpt
time
might
also
account
differ
plasma
triglycerid
cholesterol
concentr
dietari
group
similar
concentr
nonesterifi
fatti
acid
indic
energi
balanc
dietari
group
equal
lipid
mobil
seem
minor
import
maintain
energi
balanc
previou
studi
also
fail
demonstr
consist
effect
neonat
calv
expect
concentr
total
protein
plasma
increas
colostrumf
group
although
protein
content
formula
colostrum
similar
decreas
albumin
concentr
day
day
probabl
caus
hemodilut
first
feed
intak
coincid
previou
find
ig
albumin
concentr
plasma
affect
colostrum
feed
differ
total
protein
like
caus
absorpt
colostr
immunoglobulin
colostrum
intak
colostrum
intak
import
matur
process
also
acquir
passiv
immun
bovin
placenta
imperm
antibodi
review
weaver
et
al
calv
serum
igg
concentr
gl
total
protein
gl
h
birth
suffer
failur
passiv
transfer
associ
increas
morbid
mortal
well
reduc
perform
studi
colostrumf
calv
exceed
threshold
howev
failur
passiv
transfer
relev
problem
formulaf
calv
although
parenter
supplement
bovin
immunoglobulin
day
formulaf
calv
show
slight
hyperthermia
first
day
life
higher
incid
diarrhea
probabl
caus
gastrointestin
inflamm
due
miss
local
immun
accompani
abdomin
pain
diminish
appetit
obvious
parenter
oral
treatment
immunoglobulin
could
prevent
local
system
infect
formulaf
calv
probabl
miss
herdspecif
immunoglobulin
formula
administ
drug
howev
perform
microbiolog
analys
fece
calv
determin
pathogen
might
caus
loos
fece
time
cours
plasma
igm
concentr
formulaf
calv
indic
indigen
product
igm
evid
earli
day
life
concentr
low
effect
protect
infect
assum
inflammatori
process
also
activ
synthesi
acut
phase
protein
although
increas
plasma
acut
phase
protein
calv
emphas
immunolog
burden
new
environ
higher
haptoglobin
concentr
formulaf
calv
suggest
sever
inflammatori
process
colostrumf
calv
underlin
greater
incid
gastrointestin
infect
serum
amyloid
suscept
stress
includ
physic
stress
suppos
plasma
concentr
equal
high
group
due
experiment
procedur
eg
continu
venipunctur
restrict
feed
singl
pen
tempor
fixat
dietari
chang
mrna
level
find
differ
acut
phase
protein
dietari
group
hepat
transcript
preced
translat
protein
releas
circul
thu
obvious
miss
time
point
elev
mrna
abund
hp
howev
mrna
abund
crp
moder
acut
phase
protein
elev
formulaf
group
day
could
indic
import
creactiv
protein
major
compon
bovin
innat
immun
system
henc
increas
creactiv
protein
product
compens
absenc
immunoglobulin
colostrumdepriv
calv
regard
proinflammatori
cytokin
found
elev
hepat
mrna
abund
tnf
quercetinsuppl
calv
differ
dietari
group
immunocompet
condit
impact
variou
noxa
lead
local
product
proinflammatori
cytokin
eg
tumor
necrosi
factor
tnf
turn
induc
system
acut
phase
respons
includ
synthesi
acut
phase
protein
within
signal
transduct
reactiv
oxygen
speci
act
second
messeng
thu
enhanc
tnfinduc
gene
express
oxid
condit
potenti
activ
respect
pathway
although
high
dose
quercetin
repeatedli
shown
reduc
mrna
express
tnf
vitro
applic
prophylact
dose
increas
ratio
pro
antiinflammatori
cytokin
murin
macrophag
assum
hepat
quercetin
concentr
experi
exceed
prophylact
dose
thu
quercetin
might
increas
express
tnf
unfortun
measur
tnf
protein
concentr
suppos
posttranscript
process
anticip
tnf
signal
transduct
quercetin
scaveng
reactiv
oxygen
speci
necessari
signal
transduct
therefor
observ
quercetin
effect
tnf
gene
express
could
forward
express
target
gene
eg
acut
phase
protein
would
expect
otherwis
concern
antioxid
statu
plasma
previou
find
neonat
calv
inconsist
inanami
et
al
stohrer
lutz
stangassing
conclud
comparison
calv
dam
former
highli
suscept
oxid
stress
due
immatur
defens
system
wherea
et
al
deduc
high
frap
valu
despit
high
reactiv
oxygen
speci
calv
wellprepar
address
oxid
stress
although
increas
teac
previou
studi
group
indic
rise
antioxid
capac
first
week
life
result
support
determin
frap
anoth
marker
antioxid
capac
furthermor
valu
tbar
serv
proxi
measur
product
lipid
peroxid
unaffect
age
studi
contradict
earlier
studi
howev
reliabl
tbar
critic
low
sensit
specif
use
recommend
reliabl
approach
assess
oxid
stress
vivo
time
cours
significantli
decreas
calv
thu
support
theori
exposur
oxygenrich
environ
follow
hypoxia
birth
result
sever
oxid
stress
newborn
although
quercetin
known
exert
antioxid
effect
find
improv
antioxid
statu
plasma
calv
increas
hepat
express
antioxid
enzym
line
previou
find
group
research
conduct
neonat
calv
lactat
dairi
cow
oral
administ
quercetin
complet
metabol
insid
intestin
mucosa
thu
gastrointestin
tract
first
site
action
quercetin
pathogen
gastrointestin
disord
commonli
occur
first
week
life
examin
intestin
tissu
exclud
local
effect
quercetin
antioxid
statu
except
paramet
antioxid
system
plasma
higher
colostrum
feed
colostrum
sourc
reactiv
oxygen
speci
also
contain
varieti
antioxid
factor
latter
increas
time
parturit
absorpt
pro
antioxid
present
colostrum
might
contribut
rise
respect
paramet
plasma
colostrumf
calv
trigger
immunolog
process
turn
caus
elev
plasma
level
howev
hepat
mrna
abund
antioxid
enzym
seem
affect
diet
group
fed
milk
replac
day
onward
potenti
dietari
effect
hepat
antioxid
statu
might
longlast
conclus
oral
administr
quercetin
aglycon
daili
dose
mgkg
bodi
weight
newborn
calv
first
week
life
unabl
compens
inadequ
colostrum
suppli
quercetin
show
posit
effect
neonat
antioxid
antiinflammatori
statu
wherea
colostrum
feed
improv
neonat
health
statu
support
passiv
immun
promot
antioxidativeoxid
statu
